NYSE:ELV

Elevance Health (ELV) Stock Forecast, Price & News

$460.13

-4.47 (-0.96%)

(As of 06/7/2023 ET)

Compare

Today's Range: $459.54
▼
$465.70
50-Day Range: $441.60
▼
$496.20
52-Week Range: $438.56
▼
$549.52

Volume: 1.49 million shs
Average Volume: 1.09 million shs
Market Capitalization: $109.08 billion

P/E Ratio: 17.90
Dividend Yield: 1.29%
Price Target: $570.60

Elevance Health MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.92 Rating Score
Upside/Downside: 24.0% Upside
$570.60 Price Target
Short Interest: Healthy
0.78% of Float Sold Short
Dividend Strength: Strong
Based on Four Factors
Sustainability: N/A
News Sentiment: 0.51
Based on 16 Articles This Week
Insider Trading: Selling Shares
$6.71 M Sold Last Quarter
Proj. Earnings Growth: 12.72%
From $32.78 to $36.95 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.28 out of 5 stars

Medical Sector

2nd out of 981 stocks

Hospital & Medical Service Plans Industry

2nd out of 11 stocks

3.5

Analyst's Opinion

Consensus Rating
Elevance Health has received a consensus rating of Buy. The company's average rating score is 2.92, and is based on 11 buy ratings, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $570.60, Elevance Health has a forecasted upside of 24.0% from its current price of $460.13.
Amount of Analyst Coverage
Elevance Health has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

5.0

Short Interest

Percentage of Shares Shorted
0.78% of the float of Elevance Health has been sold short.
Short Interest Ratio / Days to Cover
Elevance Health has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Elevance Health has recently decreased by 7.07%, indicating that investor sentiment is improving significantly.

4.2

Dividend Strength

Dividend Yield
Elevance Health pays a meaningful dividend of 1.23%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Elevance Health has been increasing its dividend for 12 years.
Dividend Coverage
The dividend payout ratio of Elevance Health is 23.04%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Elevance Health will have a dividend payout ratio of 16.02% next year. This indicates that Elevance Health will be able to sustain or increase its dividend.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for ELV.

2.5

News and Social Media Coverage

News Sentiment
Elevance Health has a news sentiment score of 0.51. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 16 news articles for Elevance Health this week, compared to 8 articles on an average week.
Search Interest
Only 24 people have searched for ELV on MarketBeat in the last 30 days. This is a decrease of -58% compared to the previous 30 days.
MarketBeat Follows
15 people have added Elevance Health to their MarketBeat watchlist in the last 30 days. This is an increase of 25% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Elevance Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $6,714,986.00 in company stock.
Percentage Held by Insiders
Only 0.35% of the stock of Elevance Health is held by insiders.
Percentage Held by Institutions
87.66% of the stock of Elevance Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Elevance Health are expected to grow by 12.72% in the coming year, from $32.78 to $36.95 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Elevance Health is 17.90, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 136.17.
Price to Earnings Ratio vs. Sector
The P/E ratio of Elevance Health is 17.90, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 100.45.
Price to Earnings Growth Ratio
Elevance Health has a PEG Ratio of 1.21. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Elevance Health has a P/B Ratio of 3.03. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Elevance Health (NYSE:ELV) Stock

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Receive ELV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elevance Health and its competitors with MarketBeat's FREE daily newsletter.

ELV Stock News Headlines

June 8, 2023 | americanbankingnews.com

Zacks Research Equities Analysts Cut Earnings Estimates for Elevance Health, Inc. (NYSE:ELV)

June 7, 2023 | msn.com

Elevance Health goes ex-dividend tomorrow

June 8, 2023 | Edge On The Street (Ad)

The Real Problem With "Made in America" Lithium

Politicians love to say they support "Made in America" when it comes to manufacturing. But when it comes to lithium - the metal fueling our transition to electric vehicles - it's not that simple.

June 5, 2023 | msn.com

Elevance Health: A Critical Update (Rating Downgrade)

June 5, 2023 | finance.yahoo.com

Elevance Health Announces Appearance at Goldman Sachs 44th Annual Global Healthcare Conference

June 4, 2023 | americanbankingnews.com

Elevance Health, Inc. (NYSE:ELV) Receives $570.60 Consensus PT from Brokerages

June 4, 2023 | americanbankingnews.com

Zacks Research Brokers Lift Earnings Estimates for Elevance Health, Inc. (NYSE:ELV)

June 1, 2023 | bizjournals.com

Natalie Cooper named president of Amerigroup Tennessee

June 8, 2023 | Edge On The Street (Ad)

The Real Problem With "Made in America" Lithium

Politicians love to say they support "Made in America" when it comes to manufacturing. But when it comes to lithium - the metal fueling our transition to electric vehicles - it's not that simple.

June 1, 2023 | msn.com

Elevance Health Unusual Options Activity For June 01

June 1, 2023 | americanbankingnews.com

Zacks Research Equities Analysts Lift Earnings Estimates for Elevance Health, Inc. (NYSE:ELV)

May 22, 2023 | finance.yahoo.com

Here's Why You Should Hold Elevance (ELV) in Your Portfolio

May 19, 2023 | businesswire.com

Elevance Health Announces Appearance at the Bernstein 39 th Annual Strategic Decisions Conference

May 19, 2023 | finance.yahoo.com

Why Is Elevance Health (ELV) Up 0% Since Last Earnings Report?

May 19, 2023 | americanbankingnews.com

Elevance Health (NYSE:ELV) Coverage Initiated by Analysts at StockNews.com

May 18, 2023 | finance.yahoo.com

Elevance Health Announces Appearance at the Bernstein 39th Annual Strategic Decisions Conference

May 18, 2023 | finance.yahoo.com

Is Elevance Health (ELV) Trading at a Reasonable Valuation?

May 15, 2023 | americanbankingnews.com

Elevance Health, Inc. (NYSE:ELV) Short Interest Up 20.7% in April

May 12, 2023 | finance.yahoo.com

Elevance Health, Inc.: Raising EPS estimates

May 8, 2023 | americanbankingnews.com

Elevance Health, Inc. (NYSE:ELV) Receives $572.19 Average Price Target from Analysts

May 6, 2023 | finance.yahoo.com

Elevance Health, Inc. (ELV)

May 5, 2023 | benzinga.com

Elevance Health Announces Appearance at the 2023 RBC Capital Markets Global Healthcare Conference

May 3, 2023 | americanbankingnews.com

FY2023 EPS Estimates for Elevance Health, Inc. Boosted by Analyst (NYSE:ELV)

May 1, 2023 | finance.yahoo.com

ELV vs. AMEH: Which Stock Is the Better Value Option?

May 1, 2023 | americanbankingnews.com

Elevance Health (NYSE:ELV) Stock Rating Reaffirmed by 22nd Century Group

April 28, 2023 | finance.yahoo.com

AMN Healthcare (AMN) to Post Q1 Earnings: What's in the Cards?

April 28, 2023 | americanbankingnews.com

Elevance Health (NYSE:ELV) Stock Rating Upgraded by Morgan Stanley

See More Headlines

ELV Price History

30 days | 90 days | 365 days | Advanced Chart

ELV Company Calendar

Ex-Dividend for 3/24 Dividend: 3/09/2023
Dividend Payable: 3/24/2023
Last Earnings: 4/19/2023
Today: 6/08/2023
Ex-Dividend for 6/23 Dividend: 6/08/2023
Dividend Payable: 6/23/2023
Next Earnings (Estimated): 7/19/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Hospital & medical service plans
Sub-Industry: Managed Health Care
Sector: Medical
Current Symbol: NYSE:ELV
CUSIP: 94973V10
CIK: 1156039
Web: www.antheminc.com
Phone: (800) 331-1476
Fax: 317-488-6275
Employees: 102,300
Year Founded: 2004

Price Target and Rating

Average Stock Price Forecast: $570.60
High Stock Price Forecast: $610.00
Low Stock Price Forecast: $547.00
Forecasted Upside/Downside: +24.0%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.92
Research Coverage: 12 Analysts

Profitability

EPS (Most Recent Fiscal Year): $25.70
Trailing P/E Ratio: 17.90
Forward P/E Ratio: 14.04
P/E Growth: 1.21
Net Income: $6.03 billion
Net Margins: 3.86%
Pretax Margin: 5.03%
Return on Equity: 20.05%
Return on Assets: 7.03%

Debt

Debt-to-Equity Ratio: 0.67
Current Ratio: 1.43
Quick Ratio: 1.43

Sales & Book Value

Annual Sales: $156.60 billion
Price / Sales: 0.70
Cash Flow: $34.86 per share
Price / Cash Flow: 13.20
Book Value: $151.64 per share
Price / Book: 3.03

Miscellaneous

Outstanding Shares: 237,060,000
Free Float: 236,226,000
Market Cap: $109.08 billion
Optionable: Optionable
Beta: 0.85

Social Links

Key Executives

Gail Koziara Boudreaux
President, Chief Executive Officer & Director

John Edward Gallina
Chief Financial Officer & Executive Vice President

Dustin Wilcox
VP & Chief Information Security Officer

Peter David Haytaian
Executive VP, President-Carelon & CarelonRX

Morgan Kendrick
EVP & President-Commercial & Specialty Business

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

ELV Stock - Frequently Asked Questions

Should I buy or sell Elevance Health stock right now?: 12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Elevance Health in the last twelve months. There are currently 1 hold rating and 11 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ELV shares.
View ELV analyst ratings or view top-rated stocks.
What is Elevance Health's stock price forecast for 2023?: 12 brokers have issued 12-month price objectives for Elevance Health's stock. Their ELV share price forecasts range from $547.00 to $610.00. On average, they expect the company's share price to reach $570.60 in the next year. This suggests a possible upside of 24.0% from the stock's current price.
View analysts price targets for ELV or view top-rated stocks among Wall Street analysts.
How have ELV shares performed in 2023?: Elevance Health's stock was trading at $512.97 at the start of the year. Since then, ELV shares have decreased by 10.3% and is now trading at $460.13.
View the best growth stocks for 2023 here.
Are investors shorting Elevance Health?: Elevance Health saw a decline in short interest in May. As of May 15th, there was short interest totaling 1,840,000 shares, a decline of 7.1% from the April 30th total of 1,980,000 shares. Based on an average trading volume of 1,090,000 shares, the short-interest ratio is presently 1.7 days. Approximately 0.8% of the shares of the company are short sold.
View Elevance Health's Short Interest.
When is Elevance Health's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 19th 2023.
View our ELV earnings forecast.
How were Elevance Health's earnings last quarter?: Elevance Health, Inc. (NYSE:ELV) issued its earnings results on Wednesday, April, 19th. The company reported $9.46 EPS for the quarter, topping analysts' consensus estimates of $9.26 by $0.20. The business had revenue of $41.90 billion for the quarter, compared to the consensus estimate of $40.93 billion. Elevance Health had a net margin of 3.86% and a trailing twelve-month return on equity of 20.05%. Elevance Health's quarterly revenue was up 10.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $8.25 EPS.
How often does Elevance Health pay dividends? What is the dividend yield for Elevance Health?: Elevance Health declared a quarterly dividend on Thursday, April 20th. Shareholders of record on Friday, June 9th will be paid a dividend of $1.48 per share on Friday, June 23rd. This represents a $5.92 annualized dividend and a dividend yield of 1.29%. The ex-dividend date is Thursday, June 8th.
Read our dividend analysis for ELV.
What ETFs hold Elevance Health's stock?: ETFs with the largest weight of Elevance Health (NYSE:ELV) stock in their portfolio include iShares U.S. Healthcare Providers ETF (IHF), Guru Favorite Stocks ETF (GFGF), Simplify Health Care ETF (PINK), Alpha Intelligent - Large Cap Value ETF (AILV), Victoryshares Dividend Accelerator ETF (VSDA), Corbett Road Tactical Opportunity ETF (OPPX), T. Rowe Price Equity Income ETF (TEQI) and iShares U.S. Healthcare ETF (IYH).

Is Elevance Health a good dividend stock?: Elevance Health (NYSE:ELV) pays an annual dividend of $5.92 per share and currently has a dividend yield of 1.23%. The company has been increasing its dividend for 12 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 23.04%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ELV will have a dividend payout ratio of 16.02% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ELV.
What guidance has Elevance Health issued on next quarter's earnings?: Elevance Health issued an update on its FY 2023 earnings guidance on Wednesday, April, 19th. The company provided earnings per share (EPS) guidance of $32.70- for the period, compared to the consensus EPS estimate of $37.00. The company issued revenue guidance of -.
What is Elevance Health's stock symbol?: Elevance Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "ELV."
Who are Elevance Health's major shareholders?: Elevance Health's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (8.79%), Price T Rowe Associates Inc. MD (5.60%), State Street Corp (4.62%), Wellington Management Group LLP (3.57%), FMR LLC (2.03%) and Geode Capital Management LLC (1.80%). Insiders that own company stock include Charles Morgan Kendrick Jr, Gloria M Mccarthy, John E Gallina, Julie A Hill, Peter D Haytaian, Ramiro G Peru, Robert L Dixon Jr, Ronald W Penczek and Ryan M Schneider.
View institutional ownership trends.
How do I buy shares of Elevance Health?: Shares of ELV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Elevance Health's stock price today?: One share of ELV stock can currently be purchased for approximately $460.13.
How much money does Elevance Health make?: Elevance Health (NYSE:ELV) has a market capitalization of $109.08 billion and generates $156.60 billion in revenue each year. The company earns $6.03 billion in net income (profit) each year or $25.70 on an earnings per share basis.
How many employees does Elevance Health have?: The company employs 102,300 workers across the globe.
Does Elevance Health have any subsidiaries?: The following companies are subsidiares of Elevance Health: 1-800 Contacts, AIM Specialty Health, AMERIGROUP Community Care of New Mexico Inc., AMERIGROUP Corporation, AMERIGROUP Maryland Inc., AMERIGROUP New Jersey Inc., AMERIGROUP Ohio Inc., AMERIGROUP Tennessee Inc., AMERIGROUP Texas Inc., AMERIGROUP Washington Inc., AMGP Georgia Managed Care Company Inc., ATH Holding Company LLC, America's 1st Choice of South Carolina Inc., America's Health Management Services Inc., American Imaging Management Inc., America’s 1st Choice, Amerigroup, Amerigroup Delaware Inc., Amerigroup District of Columbia Inc., Amerigroup Health Plan of Louisiana Inc., Amerigroup IPA of New York LLC, Amerigroup Insurance Company, Amerigroup Iowa Inc., Amerigroup Kansas Inc., Amerigroup Mississippi Inc., Amerigroup Oklahoma Inc., Amerigroup Partnership Plan LLC, Amerigroup Pennsylvania Inc., Anthem Blue Cross Life and Health Insurance Company, Anthem Financial Inc., Anthem Health Plans Inc., Anthem Health Plans of Kentucky Inc., Anthem Health Plans of Maine Inc., Anthem Health Plans of New Hampshire Inc., Anthem Health Plans of Virginia Inc., Anthem Holding Corp., Anthem Innovation Israel Ltd., Anthem Insurance Companies Inc., Anthem Kentucky Managed Care Plan Inc., Anthem Life & Disability Insurance Company, Anthem Life Insurance Company, Anthem Partnership Holding Company LLC, Anthem Services Company LLC, Anthem Southeast Inc., Anthem UM Services Inc., Anthem Workers' Compensation LLC, Applied Pathways LLC, Arcus Enterprises Inc., Aspire Health Inc., Aspire Healthcare Corp, Associated Group Inc., Beacon Health Options, Blue Cross Blue Shield Healthcare Plan of Georgia Inc., Blue Cross Blue Shield of Wisconsin, Blue Cross of California, Blue Cross of California Partnership Plan Inc., CareMarket Inc., CareMore Health Plan, CareMore Health Plan of Arizona Inc., CareMore Health Plan of Nevada, CareMore Health Plan of Texas Inc., CareMore Health System, CareMore LLC, Cerulean Companies Inc., Claim Management Services Inc., Community Care Health Plan of Louisiana Inc., Community Care Health Plan of Nevada Inc., Community Insurance Company, Compcare Health Services Insurance Corporation, Crossroads Acquisition Corp., DBG Holdings Inc., DeCare Analytics LLC, DeCare Dental Health International LLC, DeCare Dental Insurance Ireland Ltd., DeCare Dental LLC, DeCare Dental Networks LLC, DeCare Operations Ireland Limited, Delivery Network LLC, Designated Agent Company Inc., EHC Benefits Agency Inc., EasyScripts Cutler Bay LLC, EasyScripts Hialeah LLC, EasyScripts LLC, EasyScripts Westchester LLC, Empire HealthChoice Assurance Inc., Empire HealthChoice HMO Inc., Federal Government Solutions LLC, Freedom Health Inc., Global TPA LLC, Golden West Health Plan Inc., Greater Georgia Life Insurance Company, HEP AP Holdings Inc., HMO Colorado Inc., HMO Missouri Inc., Health Core Inc., Health Management Corporation, Health Ventures Partner L.L.C., HealthKeepers Inc., HealthLink HMO Inc., HealthLink Inc., HealthLink Insurance Company, HealthPlus HP LLC, HealthSun Health Plans, HealthSun Health Plans Inc., HealthSun Holdings LLC, HealthSun Management LLC, HealthSun Physicians Network I LLC, HealthSun Physicians Network LLC, Healthy Alliance Life Insurance Company, Highland Acquisition Holdings LLC, Highland Holdco Inc., Highland Intermediate Holdings LLC, Highland Investor Holdings LLC, Imaging Management Holdings LLC, IngenioRx Inc., Legato Health Technologies LLP, Legato Health Technologies Philippines Inc., Legato Holdings I Inc., Legato Holdings II LLC, Living Complete Technologies Inc., Matthew Thornton Health Plan Inc., Memphis Supportive Care Partnership LLC, Meridian Resource Company LLC, Missouri Care Incorporated, NGS Federal LLC, Nash Holding Company LLC, National Government Services Inc., New England Research Institutes Inc., Optimum Healthcare Inc., Park Square Holdings Inc., Park Square I Inc., Park Square II Inc., Pasteur Medical Bird Road LLC, Pasteur Medical Center LLC, Pasteur Medical Cutler Bay LLC, Pasteur Medical Group LLC, Pasteur Medical Hialeah Gardens LLC, Pasteur Medical Holdings LLC, Pasteur Medical Kendall LLC, Pasteur Medical Management LLC, Pasteur Medical Miami Gardens LLC, Pasteur Medical North Miami Beach LLC, Pasteur Medical Partners LLC, Resolution Health Inc, Resolution Health Inc., RightCHOICE Managed Care Inc., Rocky Mountain Hospital and Medical Service Inc., SellCore Inc., Simply Healthcare Holdings, Simply Healthcare Plans Inc., Southeast Services Inc., State Sponsored DM Services Inc., The Anthem Companies Inc., The Anthem Companies of California Inc., TrustSolutions LLC, UNICARE Health Plan of West Virginia Inc., UNICARE Illinois Services Inc., UNICARE National Services Inc., UniCare Life & Health Insurance Company, UniCare Specialty Services Inc., Valus Inc., WPMI LLC, WellCare of Nebraska Inc., WellPoint Acquisition LLC, WellPoint California Services Inc., WellPoint Dental Services Inc., WellPoint Health Solutions Inc., WellPoint Holding Corp., WellPoint Information Technology Services Inc., WellPoint Insurance Services Inc., WellPoint Military Care Corporation, Wellmax Health Medical Centers LLC, Wellmax Health Physicians Network LLC, and Wisconsin Collaborative Insurance Company.
Read More
How can I contact Elevance Health?: Elevance Health's mailing address is 220 VIRGINIA AVENUE, INDIANAPOLIS IN, 46204. The official website for the company is www.antheminc.com. The company can be reached via phone at (800) 331-1476, via email at chris.rigg@anthem.com, or via fax at 317-488-6275.

This page (NYSE:ELV) was last updated on 6/8/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial